Author:
Mittendorf E.A.,Clifton G.T.,Holmes J.P.,Schneble E.,van Echo D.,Ponniah S.,Peoples G.E.
Funder
United States Military Cancer Institute
Department of Surgery, Uniformed Services University of the Health Sciences
Clinical Breast Care Project
Department of Clinical Investigation, Walter Reed Army Medical Center
NIH
Reference19 articles.
1. The E75 HER2/neu peptide vaccine;Mittendorf;Cancer Immunol Immunother,2008
2. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells;Brossart;Blood,2000
3. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines;Disis;J Clin Oncol,2002
4. Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369–377, results in short-lived peptide-specific immunity;Knutson;Clin Cancer Res,2002
5. Immunization with a peptide epitope (p369–377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors;Zaks;Cancer Res,1998
Cited by
202 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献